Tang Liang, Zhou Shenghua, Shen Xiangqian
Department of Cardiology, the Second Xiangya Hospital of Central South University, Changsha 410011, People's Republic of China.
Tex Heart Inst J. 2014 Feb;41(1):83-6. doi: 10.14503/THIJ-12-2927.
Percutaneous closure of patent arterial ducts with the Amplatzer Ductal Occluder has become an effective and widely accepted alternative to surgical management. Although rarely, the occluder can be dislodged after an initially successful deployment, and with catastrophic consequences. We describe such a case in a 12-month-old girl who underwent transcatheter closure of a patent arterial duct. After device deployment, the occluder embolized in the patient's descending thoracic aorta, and severe spinal cord ischemic injury resulted. To our knowledge, ours is the first report of this complication after the deployment of an Amplatzer Ductal Occluder. We discuss pathophysiologic mechanisms that could expose patients to the risk of device dislodgment, and we review the relevant medical literature.
使用Amplatzer动脉导管封堵器经皮闭合动脉导管未闭已成为手术治疗的一种有效且被广泛接受的替代方法。尽管这种情况很少见,但封堵器在最初成功植入后可能会移位,并带来灾难性后果。我们描述了一名12个月大女童经导管闭合动脉导管未闭的病例。在植入封堵器后,封堵器栓塞至患者胸降主动脉,导致严重的脊髓缺血性损伤。据我们所知,这是首例Amplatzer动脉导管封堵器植入后出现这种并发症的报告。我们讨论了可能使患者面临封堵器移位风险的病理生理机制,并回顾了相关医学文献。